Great Point Partners as of March 31, 2019
Portfolio Holdings for Great Point Partners
Great Point Partners holds 36 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 7.2 | $72M | 615k | 117.70 | |
| Ptc Therapeutics I (PTCT) | 6.8 | $68M | 1.8M | 37.64 | |
| Zogenix | 6.5 | $66M | 1.2M | 55.01 | |
| Global Blood Therapeutics In | 6.2 | $63M | 1.2M | 52.93 | |
| Audentes Therapeutics | 6.1 | $61M | 1.6M | 39.02 | |
| ACADIA Pharmaceuticals (ACAD) | 5.3 | $54M | 2.0M | 26.85 | |
| Iovance Biotherapeutics (IOVA) | 5.2 | $53M | 5.6M | 9.51 | |
| Acceleron Pharma | 5.0 | $50M | 1.1M | 46.57 | |
| Array BioPharma | 4.8 | $49M | 2.0M | 24.38 | |
| BioCryst Pharmaceuticals (BCRX) | 4.8 | $49M | 6.0M | 8.14 | |
| Intercept Pharmaceuticals In | 4.4 | $45M | 400k | 111.86 | |
| United Therapeutics Corporation (UTHR) | 4.4 | $45M | 380k | 117.37 | |
| Kura Oncology (KURA) | 4.3 | $44M | 2.6M | 16.59 | |
| Puma Biotechnology (PBYI) | 3.5 | $35M | 900k | 38.79 | |
| Five Prime Therapeutics | 3.2 | $32M | 2.4M | 13.40 | |
| Genfit S A ads (GNFT) | 2.9 | $30M | 1.2M | 24.00 | |
| Dermira | 2.8 | $28M | 2.1M | 13.55 | |
| Epizyme | 2.7 | $27M | 2.2M | 12.39 | |
| Millendo Therapeutics | 1.9 | $19M | 1.3M | 15.00 | |
| Krystal Biotech (KRYS) | 1.6 | $16M | 492k | 32.90 | |
| Menlo Therapeutics | 1.6 | $16M | 2.1M | 7.85 | |
| Cymabay Therapeutics | 1.3 | $13M | 999k | 13.28 | |
| Fibrogen (FGEN) | 1.1 | $11M | 200k | 54.35 | |
| Cytomx Therapeutics (CTMX) | 1.0 | $10M | 959k | 10.75 | |
| Biohaven Pharmaceutical Holding | 1.0 | $10M | 200k | 51.47 | |
| Foamix Pharmaceuticals | 1.0 | $10M | 2.7M | 3.75 | |
| Zafgen | 0.8 | $8.5M | 3.1M | 2.74 | |
| Osmotica Pharmaceuticals (RVLPQ) | 0.5 | $5.4M | 1.5M | 3.60 | |
| Savara (SVRA) | 0.5 | $4.9M | 660k | 7.37 | |
| Momenta Pharmaceuticals | 0.5 | $4.5M | 310k | 14.53 | |
| Proteostasis Therapeutics In | 0.4 | $4.4M | 3.5M | 1.26 | |
| Novavax | 0.3 | $3.6M | 6.5M | 0.55 | |
| Solid Biosciences | 0.2 | $1.8M | 200k | 9.20 | |
| Akebia Therapeutics (AKBA) | 0.1 | $1.1M | 132k | 8.19 | |
| Zymeworks | 0.0 | $236k | 15k | 16.15 | |
| Streamline Health Solutions (STRM) | 0.0 | $137k | 130k | 1.05 |
